GOSSAMER BIO, INC. (GOSS) Total liabilities 2022–2025
GOSSAMER BIO, INC. (GOSS) total liabilities at each fiscal year-end, per SEC filings.
$295.0MFY2025 · since FY2022: $260.4M → $295.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $295.0M | +3.2% |
| FY2024 | $285.8M | +14.7% |
| FY2023 | $249.1M | -4.3% |
| FY2022 | $260.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More GOSS financial trends
GOSS RevenueGOSS Net incomeGOSS Net marginGOSS Gross profitGOSS Gross marginGOSS Operating incomeGOSS Operating marginGOSS Operating cash flowGOSS Free cash flowGOSS Capital expendituresGOSS Return on equityGOSS Stock buybacksGOSS Dividends paidGOSS Total assetsGOSS Shareholders’ equityGOSS overview →